ArticleHeat and mass transfer = Warme- und Stoffubertragung2022
Heat and mass transfer in the hyperthermia cancer treatment by magnetic nanoparticles.
Article in Heat and mass transfer = Warme- und Stoffubertragung, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 27 citations in OpenAlex.
- Multifunctional Magnetic Nanoparticles for Targeted Drug Delivery Against Cancer: A Review of Mechanisms, Applications, Consequences, Limitations, and Tailoring Strategies.Annals of biomedical engineering · 2025Review
- Advances in screening hyperthermic nanomedicines in 3D tumor models.Nanoscale horizons · 2024Review
- A Comparative Study of Cancer Cells Susceptibility to Silver Nanoparticles Produced by Electron Beam.Pharmaceutics · 2023Article
- Validation of a Temperature-Feedback Controlled Automated Magnetic Hyperthermia Therapy Device.Cancers · 2023Article
- Design of a temperature-feedback controlled automated magnetic hyperthermia therapy device.Frontiers in thermal engineering · 2023Article
- Highly sensitive near-infrared SERS nanoprobes for in vivo imaging using gold-assembled silica nanoparticles with controllable nanogaps.Journal of nanobiotechnology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, a more precise and cost-effective method is used for studying the drug delivery and distribution of magnetic nanoparticles in fluid hyperthermia cancer treatment, and numerical methods are employed to determine the effect of blood circulation on heat transfer and estimate the success of cancer treatment. A combination of numerical, analytical, and experimental researches is being conducted, which illustrates the essential role of numerical methods in medical and biomedical science. Magnetic NanoParticles' distribution and effects of infusion rate on the treatment are also discussed by considering the real distribution of MNPs. To increase accuracy and reduce costs in the in-vitro section, direct cutting and image processing methods are used instead of MRI. Based on the results of this section, with a tenfold increase in the infusion rate (4 μl/min to 40 μl/min), the penetration depth increases by 1 mm, which represents a nearly 17 percent increase. Concentrations of MNPs also decrease significantly at higher infusion rates. The simulations of heat transfer reveal that maximum temperatures occur at the lowest infusion rate (1.25 μl/min), and blood flow also has a significant effect on heat transfer. With an increase in the infusion rate, necrosis tissue recedes from the tumor center and approaches the border between the tumor and healthy tissue. Results also show that, in lower MNPs' concentrations, higher infusion rates result in better treatment even though minimum infusion rates are suggested to be the best rates to facilitate distribution and treatment.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.